Yinxue Yang

2.1k total citations
44 papers, 1.5k citations indexed

About

Yinxue Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yinxue Yang has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yinxue Yang's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Epigenetics and DNA Methylation (5 papers). Yinxue Yang is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Epigenetics and DNA Methylation (5 papers). Yinxue Yang collaborates with scholars based in China, United States and Australia. Yinxue Yang's co-authors include Shu-Feng Zhou, Hong Zhe, Yanyang Wang, Zhixu He, Xueji Zhang, Xiaoming Liu, Tianxin Yang, Yong Du, William C. Cho and Zhixu He and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Yinxue Yang

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yinxue Yang China	23	948	379	259	125	123	44	1.5k
Dong Joon Kim China	25	1.4k 1.4×	404 1.1×	320 1.2×	114 0.9×	113 0.9×	58	2.0k
Ke Yao United States	28	1.5k 1.5×	298 0.8×	389 1.5×	114 0.9×	70 0.6×	61	2.0k
Daniela Carlisi Italy	26	1.2k 1.2×	508 1.3×	283 1.1×	164 1.3×	48 0.4×	54	1.7k
Addanki P. Kumar United States	27	1.0k 1.1×	436 1.2×	561 2.2×	93 0.7×	68 0.6×	56	1.9k
Chun‐Yin Huang Taiwan	30	1.2k 1.3×	411 1.1×	463 1.8×	198 1.6×	126 1.0×	60	2.2k
Eunah Shin South Korea	24	784 0.8×	343 0.9×	353 1.4×	99 0.8×	143 1.2×	82	1.5k
John P. Alao Sweden	18	1.0k 1.1×	227 0.6×	435 1.7×	83 0.7×	63 0.5×	33	1.6k
Xianzhong Ding United States	23	843 0.9×	306 0.8×	355 1.4×	148 1.2×	245 2.0×	39	1.4k
Subhasree Nag United States	17	1.3k 1.4×	367 1.0×	549 2.1×	106 0.8×	47 0.4×	24	1.8k
Yahui Ding China	23	976 1.0×	506 1.3×	247 1.0×	99 0.8×	58 0.5×	87	1.8k

Countries citing papers authored by Yinxue Yang

Since Specialization

Citations

This map shows the geographic impact of Yinxue Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinxue Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinxue Yang more than expected).

Fields of papers citing papers by Yinxue Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinxue Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinxue Yang. The network helps show where Yinxue Yang may publish in the future.

Co-authorship network of co-authors of Yinxue Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yinxue Yang. A scholar is included among the top collaborators of Yinxue Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinxue Yang. Yinxue Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xuehong, Zhiwei Zhou, Hua Bai, et al.. (2017). The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo. BioFactors. 43(6). 812–820. 18 indexed citations

Jiang, Tao, Ling Ye, Zhongbo Han, et al.. (2017). miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses. Journal of Experimental & Clinical Cancer Research. 36(1). 131–131. 76 indexed citations

Chen, Qian, Hui Zhou, Yinxue Yang, et al.. (2017). Investigating the potential of Oxymatrine as a psoriasis therapy. Chemico-Biological Interactions. 271. 59–66. 20 indexed citations

Yang, Yinxue, Yong Du, Xiaoming Liu, & William C. Cho. (2016). Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer. Advances in experimental medicine and biology. 937. 19–51. 16 indexed citations

Wang, Yirui, Yimin Sun, Yongqing Huang, et al.. (2016). Validation of a genome-wide association study implied that SHTIN1 may involve in the pathogenesis of NSCL/P in Chinese population. Scientific Reports. 6(1). 38872–38872. 8 indexed citations

Xie, Yan, Chen Fan, Ying Dong, et al.. (2015). Functional and mechanistic investigation of Shikonin in scarring. Chemico-Biological Interactions. 228. 18–27. 18 indexed citations

Zhou, Shu-Feng, Juanjuan Yin, Yinxue Yang, et al.. (2015). Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study. Drug Design Development and Therapy. 9. 4441–4441. 25 indexed citations

Zhou, Shu‐Feng, Shuting Pan, Yiru Qin, et al.. (2015). Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells. Drug Design Development and Therapy. 9. 5511–5511. 36 indexed citations

Zhou, Shu‐Feng, Shuting Pan, Guozhi Xiao, et al.. (2015). Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Drug Design Development and Therapy. 9. 1555–1555. 63 indexed citations

10.

Zhou, Shu-Feng, Feng Wang, Qi Wang, et al.. (2015). Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells. Drug Design Development and Therapy. 9. 537–537. 53 indexed citations

11.

Chen, Zhiqiang, Ying Dong, Ningju Wang, et al.. (2014). A Novel Tri-Allelic Insertion/Deletion Polymorphism in the Promoter of p21 ^Waf1/Cip1 and the Association with Gastric Cancer. Genetic Testing and Molecular Biomarkers. 18(2). 112–116. 2 indexed citations

12.

Jiang, Jie, Xiao Zhang, Ran Huo, et al.. (2014). Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population. The Pharmacogenomics Journal. 15(4). 326–331. 8 indexed citations

13.

Zhu, Yongzhao, Jian Wang, Yukui Li, et al.. (2014). Placental mesenchymal stem cells of fetal origin deposit epigenetic alterations during long-term culture under serum-free condition. Expert Opinion on Biological Therapy. 15(2). 163–180. 19 indexed citations

14.

Jiang, Tao, Huamei Tang, Su Lu, et al.. (2013). Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer. Medical Oncology. 30(4). 715–715. 35 indexed citations

15.

Li, Minghua, Yinxue Yang, Zhi-Xu He, et al.. (2013). MicroRNA-561 Promotes Acetaminophen-Induced Hepatotoxicity in HepG2 Cells and Primary Human Hepatocytes through Downregulation of the Nuclear Receptor Corepressor Dosage-Sensitive Sex-Reversal Adrenal Hypoplasia Congenital Critical Region on the X Chromosome, Gene 1 (DAX-1). Drug Metabolism and Disposition. 42(1). 44–61. 15 indexed citations

16.

He, Zhi-Xu, Minghua Li, Yinxue Yang, et al.. (2013). Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Letters. 344(2). 239–259. 128 indexed citations

17.

Lu, Zhenhui, et al.. (2012). Overexpression of the B-type Eph and ephrin genes correlates with progression and pain in human pancreatic cancer. Oncology Letters. 3(6). 1207–1212. 15 indexed citations

18.

Huang, Guoying, Lijian Xie, Kaari L. Linask, et al.. (2011). Evaluating the role of connexin43 in congenital heart disease: Screening for mutations in patients with outflow tract anomalies and the analysis of knock-in mouse models. Journal of Cardiovascular Disease Research. 2(4). 206–212. 40 indexed citations

19.

Li, Dawei, Xiao Peng, Dongwang Yan, et al.. (2011). Msi-1 is a Predictor of Survival and a Novel Therapeutic Target in Colon Cancer. Annals of Surgical Oncology. 18(7). 2074–2083. 54 indexed citations

20.

Du, Pengcheng, Yinxue Yang, Haiying Wang, et al.. (2011). A large scale comparative genomic analysis reveals insertion sites for newly acquired genomic islands in bacterial genomes. BMC Microbiology. 11(1). 135–135. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact